intake by reducing amino-acid oxidation and protein degradation, and maintained protein synthesis at Background. Uraemia and dialysis are viewed as catabolic processes resulting in malnutrition in chronic normal levels. Metabolic acidosis impaired the downregulation of amino-acid oxidation. Maintenance dialysis renal failure (CRF ) patients. To sort out the effects of uraemia, acidosis, and dialysis on protein metabolism, treatment longitudinally restored protein flux to normal and increased protein synthesis. The general we measured leucine flux in CRF patients before and after initiation of maintenance dialysis.
one each hypertensive nephropathy and renal amyloidosis. Leucine turnover kinetics Before initiation of dialysis, mean serum urea nitrogen was 3 8.9±8.6 mmol/l and mean serum creatinine, L[1-13C ]leucine and NaH13CO 3 , >99% and >95% atom % 1087±300 mmol/l. All were clinically stable. Medications enrichment respectively, were purchased from Mass Trace included phosphate binders, iron, multivitamins, antihyper-( Woburn, MA 01801). Infusates were prepared aseptically tensive drugs, calcitriol, and in three patients recombinant the afternoon before the experiment. Intravenous catheters human erythropoietin ( Epo). None received steroid or were inserted into one arm for blood drawing and the immunosuppresive agents; one patient received levothyrox-contralateral arm for infusion; the hand/arm for blood ine. Following completion of the first two measurements, drawing was wrapped in a heating pad. In haemodialysis seven patients chose haemodialysis (HD) and one patient, patients who had an arteriovenous fistula or graft, catheters chronic ambulatory peritoneal dialysis (CAPD). One subject were inserted into the arterial and the venous ends of the did not complete the dialysis study because of renal trans-vascular access, the former for blood sampling, and the latter plantation. The single CAPD patient was using four 2-litre for infusion. exchanges daily; her weight was 46 kg. The haemodialysis Leucine kinetics were measured by a primed-constant patients were dialysed with reused F80 dialysers, using a infusion technique during substrate and isotopic steady state. 3.5mEq/l of Ca and 40 mmol bicarbonate dialysate, Kt/V The priming doses consisted of 4.0 mmol/kg of L[1-was >1.3 in all patients. The five normal control subjects 13C ]leucine and 0.11 mg/kg of NaH13CO 3 and the sustaining were not taking medication, their mean age was 50. Table 1 .
isocaproate ( KIC ) in the plasma and 13CO 2 in the expired breath were quantitated by gas chromatography-mass spectrometry and isotope ratio mass spectrometry respectively.
Experimental design
Plasma leucine was converted to heptafluorobutyryl, n-propylester and the 13C abundance was determined using positive In the CRF patients, leucine flux was measured three times, chemical ionization mass spectrometry with selected ion twice before and once after the initiation of maintenance monitoring of mass-to-charge ratio 370 and 371. The trimedialysis treatment. Before dialysis, one leucine flux was thylsilyl-quinoxalinol derivative of plasma a KIC was predetermined without sodium bicarbonate supplementation pared and 13C abundance was determined using electronand the other following at least 1 week of sodium bicarbonate impact ionization mass spectrometry with selected ion montreatment. The goal of alkali treatment was to achieve a itoring of mass-to-charge ratio 232 and 233 [18] [19] [20] . total venous CO 2 of >22 mmol/l. The sequence of these two CO 2 production rate and expired gas collection were measurements was randomized. In the control subjects, leuc-perfomred as previously described [16 ] . The first 2 h of the ine flux was measured only once.
infusion were used to achieve isotopic equilibrium, and Prior to the study, all subjects visited the Clinical Research measurements were made every 30 min during the last 2 h. Center (CRC ) nutritionist for a dietary interview and instrucLeucine flux (Q) which denotes movement of leucine into tion on dietary recording. Subsequently each subject recorded (rate of appearance (Ra)) and out of (rate of disappearance a 3-day dietary intake. Based upon the interview and the (Rd)) the metabolic pool is calculated as: dietary record, a menu for the constant diet was prepared.
Q=[E i /E p −1]×i In the CRF patients, protein and energy intake were derived from their diet record, and salt and phosphorus were where E i =L[1-13C ]leucine enrichment in the infusate which restricted to 5 g/day and 14 mg/kg/day respectively. Diet is 100%, E p =L[1-13C ]leucine or L[1-13C ]KIC enrichment was identical for all three periods. Normal subjects received in the plasma at isotopic plateau, and i=L[1-13C ]leucine their custormary dietary intake. Each subject, however, ate infusion rate (mmol/kg/h). only the constant diet prepared by the CRC for 6 days,
The rate of 13CO 2 release from tracer leucine oxidation and leucine flux was measured on the 7th day 12 h post-was calculated as follows: absorption. For the CAPD patient, peritoneal dialysis was F13CO 2 =(VCO 2 ×ECO 2 /BW)×(60×41.6/100×0.77) discontinued for 12 h before and also during the leucine flux measurement. For the HD patients, leucine flux was measured where VCO 2 is CO 2 production rate (ml/min), ECO 2 is 13CO 2 on a midweek non-dialysis day. Food unconsumed was enrichment in the expired breath at isotopic steady state, returned to the dietician for recording. The dietary intake BW is body-weight (kg). The constants 60 (min/h) and 41.6 listed in the Results section was derived from food consump-(mmol/ml at standard temperature and pressure) convert tion during the last 3 days of the constant diet.
VCO 2 from ml/min to mmol/h. The factor 100 changes moles % enrichment from a percent to a fraction. Instead of the conventional factor of 0.81 to account for the fraction of 13CO 2 produced by L[1-13C ]leucine oxidation released from were measured at baseline and every 30 min during the 3rd
The effects of uraemia, acidosis, and dialysis on leucine kinetics 1725 and 4th hour of infusion.
Leucine appearance in the plasma leucine pool infusion. The mean recovery rate for the acidotic and was derived from plasma [13C ]leucine enrichment, non-acidotic pre-dialysis patients were respectively whereas leucine appearance in the total body leuc- uraemic. Correction of acidosis, but not uraemia,
The rate of leucine oxidation (C ) is then: resulted in a reduction in 13CO 2 production. This increase in 13CO 2 production was due to enhanced
leucine oxidation as VCO 2 was not different in the
The quantitation of amino acid metabolism is based on three periods.
the mass balance relationship stating that Q=S+C=B+I, where Q is flux or total turnover rate, S is the rate of amino-
The upper half of Table 4 compares leucine kinetics acid incorporation into protein, reflecting protein synthesis, amongst the ESRD patients themselves. Both leucine C is the rate of irreversible oxidation of leucine to CO 2 , B release from protein breakdown and leucine incorporarepresents the rate of amino-acid release from endogenous tion into body protein were lower before as compared protein breakdown, and I the rate of exogenous intake. In to those after the initiation of maintenance dialysis.
the post-absorptive state, I=0, and B, therefore, equals Q.
In the presentation of our data, although we show leucine Thus maintenance dialysis increased whole-body appearance rates into the plasma and into the total body protein turnover. Leucine flux rose from 95 to leucine pool, we have only used the latter, derived from 113 mmol/kg/h, and leucine protein incorporation from plasma L[1-13C ]KIC enrichment, to calculate leucine oxida-85 to 101 mmol/kg/h. Irreversible oxidation of leucine tion and synthesis rates. Because deamination of leucine into CO 2 was highest when the patients were acidotic occurs intracellularly, and the appearance of L[1-13C ]KIC (CRF-A). C/Q and S/Q, representing the ratios of in the plasma is more representative of the movement of leucine oxidation and leucine protein incorporation to leucine in the total body leucine pool [22, 23] .
total leucine flux, changed reciprocally. During acidosis, when leucine oxidation was enhanced, C/Q rose Statistical analysis and S/Q decreased. Correction of acidosis reversed the pattern. The lower half of the table lists flux activities The differences in leucine kinetics among the three periods of normal controls; these values are most similar to of the CRF patients were assessed by one-way repeated those of the CRF patients following initiation of measures analysis of variance, and the differences between dialysis, with one exception, i.e. leucine oxidation rate any two periods by multiple paired comparisons using was lower in the dialysis patients. Fraction of leucine Student-Newman-Keuls test. The differences in leucine kinetics between the controls and the three periods of the CRF released from endogenous protein degradation that patients were assessed by Student's t test and the P values went into protein synthesis (S/Q) was actually higher were corrected using Bonferroni's method. The analyses were in ESRD patients. controls and the CRY patients are found in Tables 1  and 4 . Unlike many ESRD patients, the patients IRB approval selected for this study had no comorbid illnesses, their nutritional indices were normal; their mean body mass All protocols were approved by the Institutional Review index of 27 was not different from control (none of Board (IRB) of the University of Iowa College of Medicine. the patients had oedema), and their serum albumins were 40, 39 and 40 g/l during the A, NA, and D periods respectively. Protein and energy intake were,
Results
nonetheless, lower than that of the normal subjects. Figure 1 depicts leucine kinetics of the study subjects. Table 2 summarizes arterial blood gases and renal Leucine release from protein breakdown (Q) and leucfunction during the three study periods in the CRF ine incorporation into body protein (S) were reduced, patients. Bicarbonate and dialysis effectively corrected and leucine oxidation (C ) was increased in uraemic the metabolic acidosis; in fact, a 38 mmol dialysate and acidotic patients (CRF-A). Correction of acidosis bicarbonate concentration overcorrected the acidosis led to a reduction in leucine oxidation. Dialysis treatas total CO 2 was 30.5 mmol/l. BUN and serum creatin-ment resulted in an increase in leucine flux, both ine were significantly lower in peiod D.
protein degradation and synthesis were increased, the Table 3 illustrates two points: latter to a greater extent, and leucine oxidation rate was lower than that of the normal subjects. (a) Plasma [13C ]leucine and [13C ]KIC enrichment was Figure 2 illustrates the adaptive changes in CRF reduced and leucine appearance rates (Ra leu) in patients. When acidosis was corrected, the fraction the plasma leucine pool and body leucine pool were increased following initiation of dialysis. of leucine appearance that went into oxidation, C/Q, Table 2 . Ra, leucine appearance represents leucine released from endogenous protein breakdown. In postabsorptive state, Ra=Q or total leucine flux. Rd, leucine disappearance is the sum of leucine oxidation and leucine incorporation into body protein or protein synthesis. C/Q and S/Q are respectively ratios of oxidation and synthesis to total leucine flux. CRF-A, NA and D indicate respectively data from uraemic/ acidotic, uraemic/non-acidotic and dialysis periods. Values are presented as means±SD. Statistical differences among the three CRF periods were assessed by one-way repeated-measures ANOVA, and differences between any two periods by Student-Newman-Keuls multiple comparisons test showing P<0.05 comparing A vs NA (*), A and NA vs D ( ‡). Statistical differences between normal subjects and each of the three CRF periods were estimated by Student's t test, P values ( §) listed were corrected using Bonferroni's method.
was reduced, and that into protein synthesis, S/Q, patients and normal subjects. The readers may, however, like to refer back to Table 4 showing that protein synincreased.
For ease of the readers, we have created Table 5 thesis was significantly increased in the ESRD patients after maintenance dialysis. The fraction of leucine flux summarizing the directional changes of the different components of leucine flux in ESRD patients as com-that went into leucine oxidation (C/Q) was lower, and that went into protein synthesis (S/Q), higher after pared to normal subjects. Before initiation of dialysis whether acidosis was present or not, leucine release from correction of acidosis and initiation of dialysis. endogenous protein degradation was reduced. Leucine oxidation rate was not different from the normals in
Discussion
ESRD patients when acidotic and before dialysis (CRF-A), but was reduced following correction of acidosis and initiation of dialysis. Protein synthesis, strik-Using the technique of leucine flux measurement, we found that uraemia per se was not a catabolic state. ingly, was not statistically different between the ESRD both protein degradation and leucine oxidation increased in the presence of metabolic acidosis. In haemodialysis patients they found that protein degradation was reduced from 181 to 131 mmol/kg/h all human data, however, are consistent with hyperuraemic/acidotic, uraemic/non-acidotc and dialysis periods. Ra is the rate of leucine released from endogenous protein breakdown, catabolism. In another six predialysis patients, whose which is also equal to Q or total leucine flux. S is leucine incorpora-serum creatinines ranged from 2 to 6 mg/dl, presumtion into protein or protein synthesis, and C, leucine oxidation; * ably mildly acidotic, Goodship et al. did not find and ‡ indicate statistically significant differences comparing A vs increased protein degradation or increased leucine NA, A and NA vs D; § depicts significant differences between normal subjects and CRF patients at designated period.
oxidation; in fact those patients adapted to low protein intake similarly to the normals by reducing feedinginduced amino-acid oxidation [26 ] . The same group of authors also found mild, but statistically insignificant, reduction in leucine flux and leucine oxidation in ESRD patients before and after peritoneal dialysis treatment as compared to normal subjects [27]. Conley et al. and Berkelhammer and colleagues reported that protein turnover was decreased in children and adults with ESRD [28, 29] . Using nitrogen balance techniques, many investigators showed that both chronic renal failure and ESRD patients are able to maintain nitrogen balance despite significantly lower protein intake [30, 31] . In fact urinary urea nitrogen excretion and peritoneal dialysate urea nitrogen removal decreased proportionately with reducing dietary protein consumption [30, 32] . Furthermore, Deferrari et al. found that total amino-acid release from the leg in the post-absorptive state is similar in CRF patients and normal subjects, indicating the absence of exaggerated proteolysis [33] . Most import- Fig. 2 . Percentages (means±SEM ) of leucine appearance that went antly, many long-term diet protocols designed to examto protein synthesis (S/Q) and oxidation (C/Q) in normal subjects ine the effects of low protein diet on the progression (N ) and in CRF patients during A, NA and D representing of renal insufficiency have uniformly showed little respectively uraemic/acidotic, uraemic/non-acidotic, and dialysis per-adverse effects of protein restriction on the nutritional iods; *and ‡ indicate statistically significant differences comparing status of the studied populations [34] [35] [36] [37] [38] .
A vs NA, A and NA vs D; § depicts significant differences between normal subjects and CRF patients at designated period.
Metabolic acidosis, independent of uraemia, accelerates protein catabolism. In the rats, NH 4 Cl-induced acidosis resulted in augmented net protein degradation Not only there was no evidence of augmented catabolism, but protein turnover was actually downregulated. and increased amino-acid oxidation [39, 40] . In man, NH 4 Cl administration also increases protein breakThis finding of reduced protein breakdown is contrary to the prevailing view that uraemia is protein catabolic down and amino-acid oxidation [41] . As for uraemic acidosis, bicarbonate supplementation reduced net pro- [7, 10] . In uraemic rat models there is abundant documentation of increased protein degradation and tein degradation in both muscle incubation preparations and in hindquarter perfusion in the rats. While reduced protein synthesis during muscle incubation and hindleg perfusion studies [8, 9, [11] [12] [13] . In humans, augmented protein breakdown in NH 4
Cl-induced acidosis is abolished by adrenalectomy, uraemic acidosisReaich et al. [24] reported that in predialysis patients, related protein degradation appears not to be gluco-enhanced erythropoiesis during the initial response to Epo. corticoid-dependent [42, 43] . In humans with uraemic acidosis, Goodship and his colleagues found increases One might argue that in situations of stress such as sepsis, burns, and trauma, protein flux (Q) is also in all parameters of leucine flux in one study, and increases in only protein degradation and protein syn-increased. In those conditions, amino-acid oxidation (C ) rate is unequivocally high, and protein synthesis thesis without affecting leucine oxidation in another study [24, 25] . In the current report comparing uraemic [5] , measured by leucine flux, was reduced [44] [45] [46] . In stress, amino acids derived from muscle proteolysis patients with and without bicarbonate treatment, leucine oxidation was unequivocally higher when acidosis are oxidized for energy supply, utilized as substrate for hepatic gluconeogenesis and protein synthesis. The was present, protein degradation and synthesis both increased minimally, and these changes did not reach nitrogenous components of the amino acids are channelled to the liver for urea synthesis [47] . Accelerated statistical significance. Thus, in our hands uraemic acidosis increased primarily leucine oxidation resulting urea genesis is not seen in stable chronic uraemia on a constant diet, as was the case in our patients. in a significantly elevated C/Q, fraction of leucine release from protein breakdown that went into It could be said that a flaw in this study is the higher protein intake in the normal subjects. This flaw has no irreversible oxidation. Reciprocally, S/Q, the fraction of leucine release that went into protein synthesis, bearing on the differences amongst the CRF patients themselves studied longitudinally during treatment. was significantly reduced.
Following initiation of maintenance dialysis, the two The observed changes of increased protein flux and protein synthesis following maintenance dialysis were sides of mass balance equation (refer to Subjects and methods, Q=C+S ) changed. On the one hand, protein unrelated to dietary intake, which was fixed in all three periods. In contrast to most published reports, which turnover (Q) increased towards normal level, on the other hand, amino acid oxidation (C ) rose to a lesser consist of different patients in different stages of renal insufficiency, our study is unique in that the same degree, resulting in a greater rise in protein synthesis [5] . As shown in Table 4 , leucine-protein incorporation patients were followed longitudinally from immediately before to 8-10 weeks after initiation of dialysis, and rose from 85 to 101 mmol/kg/h. These data, at first glance, may appeared contrary to the current belief were ingesting a constant diet during all periods. This is important because metabolic status varied widely that dialyses are catabolic events. It should, however, be emphasized that the catabolic nature and dialysis is from subject to subject, but is relatively constant within the same person. based on data obtained during single dialysis procedures showing obligatory amino acid and protein loss If neither uraemia nor dialysis are catabolic, why is it that virtually every nutritional survey of CRF [14] [15] [16] and, perhaps, increased protein breakdown when using bioincompatible dialysers [17] . Our conclu-patients revealed extensive evidence of malnutrition?
First, the literature favours reporting of malnutrition. sion pertains to the longitudinal effects of maintenance dialysis treatment. These data showing improved pro-Clinical experience suggests that there are as many dialysis patients who are robustly nourished as there tein synthesis are in agreement with the commonly observed clinical feature of weight gain, increased are undernourished. The USRDS showed that in 1996, 20 and 19% respectively, of peritoneal and haemodiavigour and functional capacity following initiation of dialysis. Since dietary intake was constant in the CRF lysis patients were reported as undernourished [48] .
Second, malnutrion may be attributable to poor dietary patients during all three study periods, the improvement following dialysis could only be explained by intake and not necessary increased protein breakdown.
In summary, the current study showed that when more efficient substrate and energy utilization.
The fact that both blood pH and total CO 2 were metabolic acidosis was corrected, uraemic patients adapted successfully to the lower dietary protein/ higher following initiation of maintenance dialysis cannot exclude the possibility that the enhanced protein energy intake by downregulation of amino-acid oxidation and protein degradation with preservation of synthesis observed might be related, in part, to the mild metabolic alkalosis. None of the medication could protein synthesis capacity. After initiation of maintenance dialysis treatment, all components of protein flux, account for the change in metabolic state following dialysis. The single patient who was receiving thyroid especially protein synthesis, were accelerated, suggesting an improved body protein economy. These replacement had been on the same dosage for many years. No patient was taking glucocorticoid or andro-current findings, together with a body of literature showing that CR|F and dialysis patients are able to gen during the three study periods. Because the effect of Erythropoietin on protein metabolism is unknown, adapt to low protein intake by reducing urea generation [31] [32] [33] 49] , collectively provide an argument we were careful not to add Epo during dialysis. All the three patients who received Epo were started with against the conventional concept that uraemia and dialysis are catabolic events. this medication before and stayed on the same doses during the dialysis period. We waited for a minimum Respiratory Therapy Unit at the University of Iowa Hospital for pool specific activities to model leucine metabolism in humans. assistance in the measurement of arterial blood gases.
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